Structure Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

GPCR
Structure Therapeutics

Last Price:

$21.95

Seasonality Move:

1.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Structure Therapeutics Stock Forecast

Over the next 52 weeks, Structure Therapeutics has on average historically fallen by 12.1% based on the past 2 years of stock performance.
Structure Therapeutics has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Structure Therapeutics Stock Undervalued?

The current Structure Therapeutics [GPCR] share price is $21.76. The Score for GPCR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
GPCR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Structure Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Structure Therapeutics has on average historically fallen by 12.1% based on the past 2 years of stock performance.

Structure Therapeutics Stock Rating

Sell

Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics overpriced?

Structure Therapeutics has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Structure Therapeutics Stock Price History

Is GPCR stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

structuretx.com

52-Week Data

52-Week High:

62.74

52-Week Low:

13.22

Prediction Charts

Market Cap:

1.3B

Price in USD:

21.76

Volume:

731.3K

Beta:

-1.96

Technical Analysis

SMA50:

21.86

SMA100:

23.46

SMA200:

30.04

52-Wk Change:

-35.55%

Stock Predictions

Is Structure Therapeutics stock public?

Yes, Structure Therapeutics is a publicly traded company.
What is the Structure Therapeutics stock quote today?

The Structure Therapeutics stock price is 21.76 USD today.
How to buy Structure Therapeutics stock online?

You can buy Structure Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
May-12	26.38	24.62	26.90	24.30
May-13	25.03	23.89	25.15	23.85
May-14	24.01	23.82	24.80	21.85
May-15	23.73	24.43	24.57	22.51
May-16	24.05	25.17	26.25	23.69
May-19	25.08	25.00	25.80	24.71
May-20	24.90	24.67	25.78	24.15
May-21	24.62	24.15	25.22	23.81
May-22	24.07	24.65	25.05	23.97
May-23	24.50	24.55	24.71	24.11
May-27	24.83	23.86	24.98	22.90
May-28	23.89	22.20	23.89	22.09
May-29	22.24	22.42	22.87	22.11
May-30	22.44	21.76	22.59	21.51

Structure Therapeutics Earnings

Structure Therapeutics Earnings Report: Per Share Structure Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Structure Therapeutics Forecast Revenue Growth

Structure Therapeutics Stock Analysis: Historical quarterly revenues per share for Structure Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.78 per share.

* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.